albendazole has been researched along with Hypertension, Pulmonary in 2 studies
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orhan, G | 1 |
| Bastopcu, M | 1 |
| Aydemir, B | 1 |
| Ersoz, MS | 1 |
| Ghrairi, H | 1 |
| Khouadja, MA | 1 |
| Abouda, M | 1 |
| Ammar, J | 1 |
| Hantous, S | 1 |
| Kilani, T | 1 |
| Hamzaoui, A | 1 |
2 other studies available for albendazole and Hypertension, Pulmonary
| Article | Year |
|---|---|
Intracardiac and pulmonary artery hydatidosis causing thromboembolic pulmonary hypertension.
Topics: Adult; Albendazole; Anticestodal Agents; Echinococcosis, Pulmonary; Endarterectomy; Heart Diseases; | 2018 |
[Hydatid cyst of the heart and vessels, four cases].
Topics: Adolescent; Adult; Albendazole; Anticestodal Agents; Chemotherapy, Adjuvant; Child; Dyspnea; Echinoc | 2005 |